Literature DB >> 21331116

Medical complications in hemodialysis patients requiring vascular access radiology procedures.

Mary S Hammes1.   

Abstract

Vascular access maintenance is crucial to providing adequate hemodialysis (HD) and hence preventing signs and symptoms of uremia. The best vascular assess is a permanent arteriovenous fistula (AVF) because it has the longest survival with the least number of complications. However, because of problems with AVF maturation, the majority of HD in the United States is provided via an arteriovenous graft (AVG) or tunneled cuffed central venous catheter. The most common access complications include infection and thrombosis. For these reasons, a patient is often referred to interventional radiology for a procedure such as a catheter placement, change, or a thrombectomy with angioplasty and/or stent placement. Commonly, a HD patient will present after missing a dialysis session. This might predispose the patient to further complications. This review is intended to provide insight into some of the common medical problems (infectious, hematologic, and cardiac) facing a HD patient as a consequence of uremia. Increased awareness to these medical issues provides guidance to prevent unnecessary complications in this difficult patient population.

Entities:  

Keywords:  Hemodialysis; bacteremia; coagulation; interventional radiology; vascular access

Year:  2004        PMID: 21331116      PMCID: PMC3036219          DOI: 10.1055/s-2004-833683

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  47 in total

1.  Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial.

Authors:  G D Kamal; M A Pfaller; L E Rempe; P J Jebson
Journal:  JAMA       Date:  1991-05-08       Impact factor: 56.272

2.  Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.

Authors:  B J Manns; E D Burgess; H G Parsons; J P Schaefer; M E Hyndman; N W Scott-Douglas
Journal:  Kidney Int       Date:  1999-01       Impact factor: 10.612

3.  Frequency of antibodies directed against heparin-platelet factor 4 in patients exposed to heparin through chronic hemodialysis.

Authors:  M de Sancho; M G Lema; J Amiral; J Rand
Journal:  Thromb Haemost       Date:  1996-04       Impact factor: 5.249

Review 4.  Hemodialysis-associated hypertension: pathophysiology and therapy.

Authors:  Matthias P Hörl; Walter H Hörl
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

5.  Prosthetic fistula survival and complications in hemodialysis patients: effects of diabetes and age.

Authors:  D W Windus; M D Jendrisak; J A Delmez
Journal:  Am J Kidney Dis       Date:  1992-05       Impact factor: 8.860

6.  Hypertension in end-stage renal disease.

Authors:  V Vertes; J L Cangiano; L B Berman; A Gould
Journal:  N Engl J Med       Date:  1969-05-01       Impact factor: 91.245

7.  Cardiac failure and upper extremity arteriovenous dialysis fistulas. Case reports and a review of the literature.

Authors:  C B Anderson; J R Codd; R A Graff; M A Groce; H R Harter; W T Newton
Journal:  Arch Intern Med       Date:  1976-03

8.  Heparin-induced thrombocytopenia in hemodialysis patients.

Authors:  S Yamamoto; M Koide; M Matsuo; S Suzuki; M Ohtaka; S Saika; T Matsuo
Journal:  Am J Kidney Dis       Date:  1996-07       Impact factor: 8.860

9.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

Authors:  T E Warkentin; M N Levine; J Hirsh; P Horsewood; R S Roberts; M Gent; J G Kelton
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

10.  Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis.

Authors:  Susan I O'shea; Jeffrey H Lawson; Donal Reddan; Michael Murphy; Thomas L Ortel
Journal:  J Vasc Surg       Date:  2003-09       Impact factor: 4.268

View more
  2 in total

Review 1.  Coronary artery disease in dialysis patients: evidence synthesis, controversies and proposed management strategies.

Authors:  Alexandru Burlacu; Simonetta Genovesi; Carlo Basile; Alberto Ortiz; Sandip Mitra; Dimitrios Kirmizis; Mehmet Kanbay; Andrew Davenport; Frank van der Sande; Adrian Covic
Journal:  J Nephrol       Date:  2020-05-29       Impact factor: 3.902

2.  Hyperkalemia, Bradycardia, and Cardiac Arrest during Percutaneous Declotting of an Arteriovenous Graft.

Authors:  Charles Wiltrout
Journal:  Semin Intervent Radiol       Date:  2010-06       Impact factor: 1.513

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.